x402Pulse

Polymarket trader scorecard for any wallet: skill score (0-100), edge over the odds paid, win rate vs. the win rate the odds implied, return (ROI), realized PnL, specialty and largest open positions. Scores the latest 200 finished bets, losses included.

FDA drug recalls and food recalls: the latest FDA enforcement reports with recall class (Class I is most serious) explained in plain language, recalling firm, product, reason, status, dates and distribution. Filter by class, company and time window. openFDA data, not medical advice.

Polymarket whale trades: the largest recent buys and sells across all markets above a size you choose, with trader name, outcome, price and USD size. 5- and 15-minute crypto markets filtered out. Pair with /v1/wallet to check whether a whale is any good.

U.S. Treasury yield curve: the latest daily yields from 1 month to 30 years, the 10Y-2Y and 10Y-3M spreads, inversion flags (a closely watched recession signal) and changes vs. the previous day, a month and a year ago. Data, not investment advice.

Crude oil prices: WTI and Brent daily spot prices from the U.S. Energy Information Administration (EIA), with 1-day, 1-week, 1-month and 1-year changes, 52-week range and position in it, and the Brent-WTI spread. Official daily figures, not live futures quotes. Data, not trading advice.

Polymarket smart money for one market: the biggest holders on each side, each scored for skill (edge, win rate, ROI), plus which way skilled money leans and whether it agrees with the market's odds. Accepts a market link, slug or condition ID. Data, not investment advice.

Polymarket leaderboard re-ranked by skill, not size: top traders by edge over the odds paid, return and consistency, for day, week, month or all time, optionally per category (sports, politics, crypto, economy). Exposes big-volume losers the profit leaderboard hides.

Smart-money whale trades on Polymarket: recent large trades by skilled (Solid or Sharp) traders only, each tagged with the trader's skill score, edge over the odds paid, return and specialty. Separates informed whales from big gamblers.

Attention history for any topic: daily Wikipedia pageviews of one article (a company, person, drug, coin or event) for 7 to 90 days, with its baseline, latest day vs. baseline, spike days and 7-day trend. Use the exact article title, e.g. Bitcoin. Based on Wikimedia pageview data (CC0).

FDA drug label lookup: boxed warning, approved indications, contraindications, warnings and drug interactions for any drug, plus brand and generic names, manufacturer and route, as clean structured text from openFDA. Not medical advice.

Attention meets prediction markets: topics trending or spiking on Wikipedia matched to open Polymarket markets, each with prices and the skilled-trader lean from x402Pulse scoring. Find markets the public is suddenly paying attention to. Data, not investment advice.

Polymarket markets where smart money disagrees with the odds: scans the 30 busiest open markets every 15 minutes and returns those where skilled traders' money implies a different probability than the price, tempered against thin evidence, with a low, medium or high confidence rating. Data, not investment advice.

Trending topics: yesterday's most-viewed Wikipedia articles in any language, cleaned of site pages, with rank change vs. the day before, new entries, week-long regulars, and likely automated surges flagged separately. A daily read of what people are paying attention to. Based on Wikimedia pageview data (CC0).

FDA drug safety snapshot for any drug (brand or generic name): total adverse event reports, share serious and fatal, most-reported side effects and the quarterly report trend from FDA FAERS. Reports are not proof of causation. Data, not medical advice.

Attention spikes: Wikipedia articles whose views surged far above their usual level yesterday (ratio to the previous week's median), the earliest sign of breaking public interest in a person, company, event or idea. Any language. Likely automated traffic filtered. Based on Wikimedia pageview data (CC0).

FDA drug approvals: which companies just won FDA approval for new drugs, generics or biologics, from Drugs@FDA. Approval date, sponsor company, NDA/ANDA/BLA type, brand and active ingredients, dosage form, review priority, and a flag for novel drugs (new molecular entities). Filter by company, days and original vs. supplemental approvals.

Official exchange rates: the European Central Bank's daily reference rates for about 30 currencies, converted to any base currency (USD by default). Source: ECB statistics. Reference rates, not trading rates.

U.S. State Department travel advisories: a country's level (1 Exercise normal precautions to 4 Do not travel), summary and main risk factors, or every country at or above a level. Country by 2-letter code (MX, GB, JP) or name.

U.S. oil supply from the EIA weekly report: crude production, refinery utilization, crude imports and exports (thousand barrels per day), weekly change, 4-week average, change vs. a year ago, and net imports. Data, not trading advice.

Every current FAA disruption in U.S. airspace, ranked by severity: ground stops, ground delay programs, arrival and departure delays, airspace flow programs and real closures, with plain-language reasons. Private-aircraft-only restrictions are separated out so agents don't report them as closures. Not for flight planning.

Best hospitals ranking for a U.S. state or city from Centers for Medicare & Medicaid Services (CMS) Care Compare data: ranked by CMS star rating, then net score (quality measures better than national minus worse across mortality, safety and readmissions). Filter by city, minimum stars, emergency services and hospital type (acute, critical access, children's, psychiatric). Not medical advice.

Drug safety signal detection (pharmacovigilance) from FDA FAERS: side effects reported disproportionately often with a drug versus all other drugs, using the proportional reporting ratio (PRR) and chi-square with standard Evans criteria. A statistical prompt for study, not evidence of harm. Not medical advice.

Insider trades decoded from SEC Form 4 filings: who traded (name, role, title), buy or sell, shares, price, dollar value, holdings afterwards, and whether the trade was pre-planned under a 10b5-1 plan, plus totals and cluster-buy detection. Data, not investment advice.

Hospital scorecard for any U.S. Medicare hospital from the Centers for Medicare & Medicaid Services (CMS, the U.S. government agency): CMS overall star rating, type, ownership, emergency services, and how it compares with the national average on mortality, safety and readmissions (measures better, same, worse), plus its rank and percentile among rated hospitals in its state. Look up by CMS facilit

U.S. oil inventories from the EIA Weekly Petroleum Status Report: commercial crude, Cushing (WTI hub), Strategic Petroleum Reserve, gasoline and distillate stocks, each with the weekly build or draw, change vs. a year ago and vs. the 5-year average for the same week. Data, not trading advice.

WTI crude oil positioning from the CFTC Commitments of Traders: managed money (hedge funds) long, short and net contracts, weekly change, long/short ratio, and how extreme the net position is vs. the last 3 years (percentile), plus producers, swap dealers and open interest. Data, not trading advice.

Oil prediction markets with smart money: busy Polymarket markets about oil prices, OPEC, Strait of Hormuz and fuel, each with the skilled-trader lean (skill-weighted money vs. the market's odds) from x402Pulse scoring. Data, not trading advice.

Trip check: one call rates the delay risk (low, moderate, high) for a flight between two airports on a date, with plain-language reasons. Combines live FAA delays and ground stops, current airport weather and airport forecasts for both ends, the destination's State Department travel advisory, and the currency exchange rate for international trips. Any airport worldwide by IATA code, e.g. SFO to LH

Airport status right now: live FAA delays, ground stops, ground delay programs and closures (restrictions that only affect private aircraft are labeled as such), plus current weather in plain words and a delay-risk rating. FAA data covers U.S. airports; weather covers airports worldwide. Not for flight planning.

Standardized company financials from SEC XBRL filings: revenue, net and operating income, diluted EPS, operating cash flow for the last 8 quarters and 5 years, plus cash, assets, liabilities, equity, debt and shares outstanding, with margins, year-over-year growth and trailing-12-month totals. Handles companies that changed reporting labels. Data, not investment advice.

Material corporate events from SEC 8-K filings, decoded and ranked: bankruptcies, auditor changes, restatements, executive departures, acquisitions, major agreements, earnings releases, plus new 5%+ and activist stakes, each with a link to the filing. Data, not investment advice.

FDA drug shortages: which medicines are in shortage now, grouped by drug, with availability (unavailable or limited) per package, companies, dosage forms, shortage reasons, estimated recovery notes and posting dates. Search one drug or list current shortages. For hospitals, pharmacies and supply chains. openFDA data, not medical advice.

Airport weather forecast decoded: the next 24 to 30 hours at any airport worldwide, broken into periods with wind, gusts, visibility, cloud ceiling, flight category and a delay-risk rating, flagging when low clouds, storms, snow or strong gusts are expected. Not for flight planning.

Company brief from SEC filings in one call: latest-quarter and trailing-year financials with margins and growth, insider buying and selling over 90 days (open-market vs. pre-planned 10b5-1 trades, cluster-buy detection), material events from 8-K filings decoded into plain words, new 5%+ and activist stakes, and a plain-language summary. Any U.S.-listed ticker. Data, not investment advice.

Morning Brief for 2026's top-performing stocks (28 companies, from SanDisk and Micron to CrowdStrike and Lam Research): today's ranked signals from SEC filings (insider cluster buys, insider selling outside pre-arranged 10b5-1 plans with the main seller named, serious 8-K events, activist stakes), a one-line summary per company, and the macro backdrop (Treasury yield curve, oil positioning, skille

Weather anywhere: current conditions, the next 12 hours and a daily forecast up to about 9 days (high, low, precipitation and its chance, wind) for any coordinates or airport, in °C and °F. U.S. locations add the National Weather Service forecast in words and any active weather alerts. Sources: MET Norway worldwide, NWS for the U.S.

Every stock trade reported in President Trump's public financial disclosures for the period, in one call: ticker, company, buy or sell, reported amount range, trade and filing dates, how the stock has moved since versus the S&P 500, and a check that the filed company matches the ticker, plus the most-traded stocks. Filter by ticker or buys/sells. Facts from public filings, not investment advice.

x402Pulse Pro: a 30-day pass for $19.97 USDC that returns an API key for unlimited calls (fair use: 120 a minute, 20,000 a day) to every x402Pulse endpoint, plus an MCP server for Claude Code, Cursor and Claude Desktop. To renew, send your current key as Authorization: Bearer <key>; renewals add 30 days to the time left. The key is shown once.

Stock trades by members of Congress (House and Senate STOCK Act disclosures): member, party, chamber, buy or sell, reported amount range, trade and disclosure dates, late-disclosure flag, and how the stock has moved since the trade versus the S&P 500. By ticker (full history) or across Congress (latest), filter by member or chamber. Facts, not investment advice.

Federal government contract awards to public companies: agency, amount obligated, what it's for, award and publication dates, plus totals and (across all companies) the top recipients. By ticker or across the market, with a minimum size. Facts, not investment advice.

Stocks members of Congress report owning in their annual financial disclosures: for a ticker, which members hold it and the reported values; without a ticker, the stocks held by the most members. Facts, not investment advice.

Corporate lobbying: what a company reported spending on lobbying, on which issues and bills, and through which firms; without a ticker, the biggest corporate spenders. From federal lobbying disclosure reports. Facts, not investment advice.

Revolving-door lobbyists: people who held government jobs (Congress staff, agencies, the White House) and now lobby for a company, with their former positions, the client, the firm and the filing date. By ticker or across the market. Facts, not accusations.

Off-exchange (dark pool) trading: daily off-exchange volume and short volume for a stock with its short share versus its own 20-day average, or, without a ticker, the stocks with the highest off-exchange short share and volume on the latest trading day. Data, not investment advice.

What hedge funds and other institutions did in the latest quarter, from 13F filings: for a stock, how many funds opened, added to, trimmed or exited positions, the net dollar change and the biggest buyers and sellers; for a fund (fund=), its moves; without either, the biggest moves across the market. Data, not investment advice.

Market-wide insider trading feed: the largest open-market insider purchases and sales filed across all U.S. stocks in the last days (or for one ticker), with insider, role, shares, price, value and cluster buys (3+ insiders buying the same stock). Data, not investment advice.

App-store ratings for public companies' apps: for a ticker, each app's star rating and number of ratings with a ratings-weighted average; without a ticker, the most-rated and lowest-rated apps across public companies. A customer-satisfaction signal. Data, not investment advice.

Bills in Congress linked to money: the companies that lobbied on each bill (with amounts) and trades by members of Congress in those companies' stocks, plus each bill's latest action and official link. Search by ticker, member or bill title/number. For research, not proof of motive.